Download the Free Prime PubMed App to your smartphone or tablet.

Available for iPhone or iPad:

Unbound PubMed app for iOS iPhone iPadAlso Available:
Unbound PubMed app for Android

Available for Mac and Windows Desktops and laptops:

Unbound PubMed app for WindowsUnbound PubMed app for MAC OS Yosemite Macbook Air pro
476,090 results
  • StatPearls [BOOK]
  • BOOKStatPearls Publishing: Treasure Island (FL)
  • M Das Joe J Zito Patrick M. PM Walden University
  • Nimodipine (C21H26N2O7) is a second-generation 1,4-dihydropyridine calcium channel blocker. It was originally invented for the management of systemic hypertension.
  • StatPearls [BOOK]
  • BOOKStatPearls Publishing: Treasure Island (FL)
  • Singh Shashank S Louisiana State Un Health Science Center Preuss Charles V. CV University of South Florida
  • Carvedilol is a non-selective adrenergic blocker indicated for the chronic therapy of Heart Failure with reduced Ejection Fraction (HFrEF), hypertension and left ventricular dysfunction following myo...
  • StatPearls [BOOK]
  • BOOKStatPearls Publishing: Treasure Island (FL)
  • Yacoub Mena M Northside Hospital Sheppard Robert C. RC Northside Hospital/Un of South Florida
  • Atrial fibrillation (AF) is the most common cardiac arrhythmia encountered in the United States with about 3 million people reported being diagnosed with the disorder.[1] The prevalence of atrial fib...
  • StatPearls [BOOK]
  • BOOKStatPearls Publishing: Treasure Island (FL)
  • Miller Michael M BAMC Maani Christopher V. CV US Army
  • Due to their negative inotropic and chronotropic actions, beta-adrenergic receptor antagonists (e.g., carvedilol and metoprolol) are typically indicated in individuals with chronic cardiovascular dis...
  • Vascular and metabolic profiles in offspring born to pregnant mice with metabolic syndrome treated with inositols. [Journal Article]
  • AJAm J Obstet Gynecol 2018 Dec 03
  • Longo M, Alrais M, … Sibai BM
  • CONCLUSIONS: Inositols supplementation improved glucose tolerance, SBP and vascular responses in adult eNOS+/- and WT offspring born to dams with MS. Interestingly, WT born to MS dams show an altered vascular profile similar to eNOS+/- offspring and exhibit an improved response to INOs treatment. Our findings suggest that the benefits of INOs treatment are more pronounced in offspring exposed to environmental factors in utero, and less likely in those due to genetic factors.
  • Pharmacological treatment of obesity [English Abstract]
  • RMRev Med Inst Mex Seguro Soc 2018 11 30; 56(4):395-409
  • Ferreira-Hermosillo A, Salame-Khouri L, Cuenca-Abruch D
  • More than 70% of the population in Mexico is overweight or obese, affecting mainly people in productive age. Obesity is associated with the development of diseases that increase cardiovascular risk (...
New Search Next